CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Goldman Sachs Adjusts Price Target on Edwards Lifesciences to $102 From $98, Maintains Buy Rating

Positive
AI Analysis

Summary

Goldman Sachs raised its price target on Edwards Lifesciences to $102 from $98 while maintaining a Buy rating on the stock.

Importance:2/10
Sentiment:
0.30
price_targetratinganalyst_update
Related Companies

Read the original article

Published by yahoo_finance on July 14, 2026 11:39 AM

Read Original